[Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants].
Beaugerie
Laurent
L
Service de Gastroentérologie et Nutrition, Fédération d'Hépato-Gastro-Entérologie, Hôpital Saint-Antoine, 75571 Paris Cedex 12. laurent.beaugerie@sat.ap-hop-paris.fr
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008223:Lymphoma / Q000139:chemically induced*; D012307:Risk Factors
D007166:Immunosuppressive Agents